View Press Releases

New Research Retrieval Tool ‘Article Galaxy Widget’ Termed “The Ultimate Sophistication” by Analyst and Advisory Firm Outsell, Inc.

March 12, 2015

Article Explores Disruptive Potential of 'Article Galaxy Widget' for Researchers Who Require Fast Access to Journal Articles via Google Scholar, PubMed and Other Websites

LOS ANGELES, CA - Mar 13, 2015 - Reprints Desk, Inc., a Research Solutions (OTCQB: RSSS) company and top-rated document delivery supplier for scientific, technical and medical (STM) information, has announced the immediate full-text availability of the article The Ultimate Sophistication: Reprints Desk Launches its Article Galaxy Widget, created by independent research and advisory firm Outsell, Inc.   Authored by Outsell VP & Lead Analyst Deni Auclair, the article has been licensed by Reprints Desk as an eprint and is now freely available online at http://info.reprintsdesk.com/widget101.  

Launched in January 2015, the Article Galaxy Widget is a time-saving tool that provides web browser access to scientific, technical and medical (STM) research articles indexed by more than 50 popular search sites and discovery databases, like Google Scholar, PubMed, ResearchGATE, Web of Science and Scopus, as well as numerous publisher websites. Article Galaxy is already in use at dozens of research-oriented organizations across biotechnology, medical devices, pharmaceuticals, engineering, consulting and other research-intensive industries.

Commenting on the impact of Article Galaxy Widget’s breakthrough design for researchers, Lead Analyst Deni Auclair states, “What’s great about this widget is that it follows the “Zero Clicks Away” model, a term coined by Chuck Richard, one of our Lead Analysts.  Users can immediately see their accessibility options, as well as acquire articles with a single click. That, for researchers, is indeed a dream come true.”

Researchers simply launch the Article Galaxy Widget as a browser bookmark while they are viewing any website that references published journal articles. The widget’s intelligent user interface standardizes the search and presentation of full-text articles, and can quickly source content from existing journal subscriptions, Open Access, tokens, past single article document purchases or time-limited rentals. The widget also features quick filtering by source type, instant pricing, and a “more like this” function that identifies related scholarly papers. 

Corporations, academic institutions, and government organizations around the world rely on Reprints Desk and its online platform Article Galaxy for legal, low cost access to full-text STM content. Founded by Peter Derycz, who is also the original founder of Infotrieve, Reprints Desk has ranked #1 overall and in each category in a document delivery vendor survey of buyers conducted by Outsell.

For more information about Article Galaxy Widget, visit http://info.reprintsdesk.com/widget101.

About Outsell, Inc.®
Outsell, Inc. is the world’s only research and advisory firm focused solely on media, information, and technology. We use a time-tested, quality-proven, top-secret blend of data, brains, community, and pizzazz to produce extraordinary value for our clients. Elite information industry executives from all over the world look to Outsell for trusted advice, bold insights, and confidential access to exclusive intelligence and decision support. Outsell has your back. You’ll stay more focused, save time, grow revenue in a fast-changing global digital environment, and sleep better at night. Guaranteed.

About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Organizations fueled by intellectual property choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Reprints Desk is a wholly owned subsidiary of Research Solutions, Inc.

About Research Solutions®
Research Solutions, Inc. (OTCQB:RSSS) and its wholly-owned subsidiary Reprints Desk, Inc. (www.reprintsdesk.com) are pioneers in providing on-demand access to scientific, technical, and medical (STM) information for life science companies, academic institutions, and other research intensive organizations. Our customers include 70% of the top 25 pharma companies in the world. Our cloud based software-as-a-service (SaaS) solution, Article Galaxy, provides customers with access to the over one million newly published articles each year in addition to the tens of millions of existing articles that have been published in the past, helping them to identify the content that is critical to their research. We help our customers create and speed discoveries, save time and money, and remain copyright compliant. We have arrangements with numerous STM content publishers that allow electronic access and distribution of their content. In addition to serving end users of content, we also serve STM publishers by facilitating compliance with applicable copyright laws.

Important Cautions Regarding Forward-Looking Statements         
Certain matters discussed in this press release may be forward-looking statements.  Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission, including the financial statements and related information contained in the Company's Annual Report on Form 10-K and interim Quarterly Reports on Form 10-Q.  The Company assumes no obligation to update the cautionary information in this release.